| Package | de.medizininformatikinitiative.kerndatensatz.mtb |
| Resource Type | StructureDefinition |
| Id | mii-pr-mtb-immunohistochemistry-pdl1 |
| FHIR Version | R4 |
| Source | https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/ImplementationGuide/mii-ig-mtb-de/https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.mtb@2025.0.0-ballot&canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-immunohistochemistry-pdl1 |
| URL | https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-immunohistochemistry-pdl1 |
| Version | 2024.0.0-ballot |
| Status | draft |
| Name | MII_PR_MTB_Immunohistochemistry_PDL1 |
| Title | MII PR MTB Immunohistochemistry |
| Realm | de |
| Description | Immunhistorchemistry report |
| Type | Observation |
| Kind | resource |
No resources found
| StructureDefinition | |
| mii-pr-mtb-immunohistochemistry | MII PR MTB Immunohistochemistry |
No narrative content found in resource
FHIR{
"resourceType": "StructureDefinition",
"id": "mii-pr-mtb-immunohistochemistry-pdl1",
"url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-immunohistochemistry-pdl1",
"version": "2024.0.0-ballot",
"name": "MII_PR_MTB_Immunohistochemistry_PDL1",
"title": "MII PR MTB Immunohistochemistry",
"status": "draft",
"publisher": "Medizininformatik Initiative",
"contact": [
{
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de"
}
]
}
],
"description": "Immunhistorchemistry report",
"fhirVersion": "4.0.1",
"kind": "resource",
"abstract": false,
"type": "Observation",
"baseDefinition": "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-immunohistochemistry",
"derivation": "constraint",
"differential": {
"element": [
{
"id": "Observation.effective[x]",
"path": "Observation.effective[x]",
"type": [
{
"code": "dateTime"
}
],
"mustSupport": true
},
{
"id": "Observation.specimen",
"path": "Observation.specimen",
"short": "Probe",
"definition": "Probe"
},
{
"id": "Observation.component",
"path": "Observation.component",
"slicing": {
"discriminator": [
{
"type": "value",
"path": "code"
}
],
"rules": "open",
"description": "Immunohistochemische Ergebnisse",
"ordered": false
}
},
{
"id": "Observation.component:tps-score",
"path": "Observation.component",
"sliceName": "tps-score",
"short": "TPS-Score",
"definition": "Tumor Proportion Score (TPS) - Score für PD-L1-Expression in Tumorzellen. Der TPS ist der Anteil der PD-L1-positiven Tumorzellen im Verhältnis zu den Gesamtzellen. Der TPS wird in Prozent angegeben. Ein TPS von 1% oder mehr gilt als positiv.",
"min": 0,
"max": "1",
"mustSupport": true
},
{
"id": "Observation.component:tps-score.code",
"path": "Observation.component.code",
"patternCodeableConcept": {
"coding": [
{
"code": "C184941",
"system": "https://nih-ncpi.github.io/ncpi-fhir-ig/CodeSystem-ncit.html",
"display": "PD-L1 Tumor Proportion Score"
}
]
},
"mustSupport": true
},
{
"id": "Observation.component:tps-score.value[x]",
"path": "Observation.component.value[x]",
"slicing": {
"discriminator": [
{
"type": "type",
"path": "$this"
}
],
"ordered": false,
"rules": "open"
}
},
{
"id": "Observation.component:tps-score.value[x]:valueQuantity",
"path": "Observation.component.value[x]",
"sliceName": "valueQuantity",
"min": 0,
"max": "1",
"type": [
{
"code": "Quantity"
}
],
"mustSupport": true
},
{
"id": "Observation.component:tps-score.interpretation",
"path": "Observation.component.interpretation",
"mustSupport": true
},
{
"id": "Observation.component:cps-score",
"path": "Observation.component",
"sliceName": "cps-score",
"short": "CPS-Score",
"definition": "Combined Positive Score (CPS) - Score für PD-L1-Expression in Tumorzellen und Immunzellen. Der CPS ist der Anteil der PD-L1-positiven Tumorzellen und Immunzellen im Verhältnis zu den Gesamtzellen. Der CPS wird in Prozent angegeben. Ein CPS von 1% oder mehr gilt als positiv.",
"min": 0,
"max": "1",
"mustSupport": true
},
{
"id": "Observation.component:cps-score.code",
"path": "Observation.component.code",
"patternCodeableConcept": {
"coding": [
{
"code": "C176582",
"system": "https://nih-ncpi.github.io/ncpi-fhir-ig/CodeSystem-ncit.html",
"display": "PD-L1 Combined Positive Score"
}
]
},
"mustSupport": true
},
{
"id": "Observation.component:cps-score.value[x]",
"path": "Observation.component.value[x]",
"slicing": {
"discriminator": [
{
"type": "type",
"path": "$this"
}
],
"ordered": false,
"rules": "open"
}
},
{
"id": "Observation.component:cps-score.value[x]:valueQuantity",
"path": "Observation.component.value[x]",
"sliceName": "valueQuantity",
"min": 0,
"max": "1",
"type": [
{
"code": "Quantity"
}
],
"mustSupport": true
},
{
"id": "Observation.component:cps-score.interpretation",
"path": "Observation.component.interpretation",
"mustSupport": true
},
{
"id": "Observation.component:ics-score",
"path": "Observation.component",
"sliceName": "ics-score",
"short": "ICS-Score",
"definition": "Immune Cell Score (ICS) - Score für PD-L1-Expression in Immunzellen. Der ICS ist der Anteil der PD-L1-positiven Immunzellen im Verhältnis zu den Gesamtzellen. Der ICS wird in Prozent angegeben. Ein ICS von 1% oder mehr gilt als positiv.",
"min": 0,
"max": "1",
"mustSupport": true
},
{
"id": "Observation.component:ics-score.code",
"path": "Observation.component.code",
"patternCodeableConcept": {
"coding": [
{
"code": "C199175",
"system": "https://nih-ncpi.github.io/ncpi-fhir-ig/CodeSystem-ncit.html",
"display": "Cells.programmed cell death ligand 1/Viable tumor cells in Tissue by Immune stain"
}
]
},
"mustSupport": true
},
{
"id": "Observation.component:ics-score.value[x]",
"path": "Observation.component.value[x]",
"slicing": {
"discriminator": [
{
"type": "type",
"path": "$this"
}
],
"ordered": false,
"rules": "open"
}
},
{
"id": "Observation.component:ics-score.value[x]:valueQuantity",
"path": "Observation.component.value[x]",
"sliceName": "valueQuantity",
"min": 0,
"max": "1",
"type": [
{
"code": "Quantity"
}
],
"mustSupport": true
},
{
"id": "Observation.component:ics-score.interpretation",
"path": "Observation.component.interpretation",
"mustSupport": true
},
{
"id": "Observation.component:tc-score",
"path": "Observation.component",
"sliceName": "tc-score",
"short": "TC-Score / TPS-Score",
"definition": "Tumor Cell Score (TC-Score) - Score für PD-L1-Expression in Tumorzellen. Der TC-Score ist der Anteil der PD-L1-positiven Tumorzellen im Verhältnis zu den Gesamtzellen. Der TC-Score wird in Prozent angegeben. Ein TC-Score von 1% oder mehr gilt als positiv.",
"min": 0,
"max": "1",
"mustSupport": true
},
{
"id": "Observation.component:tc-score.code",
"path": "Observation.component.code",
"patternCodeableConcept": {
"coding": [
{
"code": "83053-9",
"system": "http://loinc.org",
"display": "Cells.programmed cell death ligand 1/Viable tumor cells in Tissue by Immune stain"
}
]
},
"mustSupport": true
},
{
"id": "Observation.component:tc-score.value[x]",
"path": "Observation.component.value[x]",
"slicing": {
"discriminator": [
{
"type": "type",
"path": "$this"
}
],
"ordered": false,
"rules": "open"
}
},
{
"id": "Observation.component:tc-score.value[x]:valueQuantity",
"path": "Observation.component.value[x]",
"sliceName": "valueQuantity",
"min": 0,
"max": "1",
"type": [
{
"code": "Quantity"
}
],
"mustSupport": true
},
{
"id": "Observation.component:tc-score.interpretation",
"path": "Observation.component.interpretation",
"mustSupport": true
}
]
}
}